Alteogen (196170) was unable to avoid weakness, swept up by the plunging KOSDAQ market conditions. On the 24th, it closed at 305,000 won in the regular session, down 1.96% (6,000 won) from the previous trading day. During the session, the stock price was pushed below the 300,000 won level, reflecting shrinking investor sentiment, but it managed to recover some losses later in the day and reclaimed the 300,000 won threshold. On the same day, the domestic stock market plunged as safe-haven sentiment spread rapidly amid escalating geopolitical risks between the U.S. and Iran. The KOSDAQ closed at 748.22, down 42.06 points (-5.32%) from the previous session, with broad-based selling pressure hitting growth stocks, including biotechs. A surge in international oil prices and concerns over expanding volatility in global financial markets further pressured investor sentiment, and domestic biotech stocks were no exception to the broader market downturn. Alteogen also saw profit-taking supply emerge as overall market sentiment deteriorated, causing the stock to briefly breach the 300,000 won level intraday. However, since surging on the 23rd to recover the 300,000 won range, the stock has been in a consolidation phase, making how it digests this short-term correction a key factor in determining its future price trajectory. Investors are closely watching whether the rebound trend can continue following the correction. In particular, next week's potential for increased market volatility driven by external factors is cited as a key variable. [This article is not intended to solicit investment. All final investment decisions and responsibilities lie with the investor.]